Free Trial

RTW Biotech Opportunities (LON:RTW) Stock Price Up 0.4% - What's Next?

RTW Biotech Opportunities logo with Financial Services background

RTW Biotech Opportunities (LON:RTW - Get Free Report) shares rose 0.4% during trading on Monday . The company traded as high as GBX 1.22 ($0.02) and last traded at GBX 1.21 ($0.02). Approximately 281,778 shares were traded during mid-day trading, an increase of 1% from the average daily volume of 278,696 shares. The stock had previously closed at GBX 1.21 ($0.02).

RTW Biotech Opportunities Price Performance

The stock has a fifty day moving average of GBX 1.19 and a two-hundred day moving average of GBX 1.26. The firm has a market capitalization of £406.46 million, a price-to-earnings ratio of 2.88 and a beta of 0.60.

RTW Biotech Opportunities Company Profile

(Get Free Report)

RTW Biotech Opportunities Ltd LSE: RTW is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in RTW Biotech Opportunities Right Now?

Before you consider RTW Biotech Opportunities, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RTW Biotech Opportunities wasn't on the list.

While RTW Biotech Opportunities currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines